Profile
DXR MDLN ISRG BDX BDXA ALC
Company Name Daxor Corporation Medline Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $71.26M $682.16B $202.33B $56.07B $55.91B $38.38B
Employees 0.04K 43.00K 15.64K 70.00K 0.00K 25.60K
CEO Michael Richard Feldschuh James Boyle David J. Rosa Thomas E. Polen Jr. - David J. Endicott
Ratings
DXR MDLN ISRG BDX BDXA ALC
Quant Rating Score 3 3 3 5 3
Quant Rating Neutral Neutral Neutral Strong Buy Neutral
Trading
DXR MDLN ISRG BDX BDXA ALC
Last Close $12.944 - $546.71 $190.98 $59.24 $76.61
High 52 $14.18 - $610.45 $249.08 $59.24 $98.3
Low 52 $7.05 - $429.59 $165.15 $59.24 $72.05
Price vs. 52 Week High -8.72 % - -10.44 % -23.33 % 0 % -22.07 %
Price vs. 52 Week Low 83.6 % - 27.26 % 15.64 % 0 % 6.33 %
Total Return
DXR MDLN ISRG BDX BDXA ALC
1 Month Return -0.01 % - 22.54 % 0.99 % 0 % 2 %
3 Month Return 17.46 % - 13.64 % -2.06 % 0 % -13.07 %
6 Month Return 69.03 % - -3 % 8.88 % 0 % -14.72 %
9 Month Return 79.03 % - -9.02 % -15.17 % 0 % -14.35 %
YTD Return 68.32 % - 4.74 % -15.82 % 0 % -9.75 %
1 Year Return 43.98 % - 1.46 % -14.22 % 0 % -10.32 %
3 Year Return 0 % - 0 % 0 % 0 % 0 %
5 Year Return 0 % - 0 % 0 % 0 % 0 %
Dividends
DXR MDLN ISRG BDX BDXA ALC
Dividend Yield Percentage (TTM) - - - 2.14 % 2.1 % 0.43 %
Dividend Paid and Capex Coverage Ration (TTM) -35008 % - 4.3 % 1.75 % 1.75 % 3.26 %
Dividend Per Share (TTM) - - - 4.17 % 4.17 % 0.33 %
Payout Ratio (TTM) - - - 71.28 % 71.28 % 15.71 %
Growth
DXR MDLN ISRG BDX BDXA ALC
Asset Growth 5.06 % 22 % -3.42 %
Gross Profit Growth -93.81 % 19.13 % 8.76 %
Revenue Growth -93.84 % 17.24 % 8.23 %
Revenue 3 Year 167.92 % 46.64 % 15.09 %
Revenue 5 Year 1702.1 % 81.77 % 32.24 %
Revenue 10 Year 140.78 % 266.32 % 50.09 %
EBIT Growth 88.46 % 32.95 % -1.5 %
Net Income Growth 91.11 % 29.18 % -1.58 %
Net Income 3 Yeari Growth Per Share -90.58 % 36.6 % -6.21 %
Net Income 5 Yeari Growth Per Share 193.54 % 64.12 % 86.87 %
Net Income 10 Yeari Growth Per Share 142.6 % 418.52 % 70.61 %
Operating Income Growth 88.46 % 32.95 % 7.55 %
Operating Cash Flow Growth (CFG) 100.7 % 33.15 % -9.69 %
Operating 3 Year CFG 100.78 % 15.88 % 29.54 %
Operating 5 Year CFG -99.29 % 47.28 % -5.66 %
Operating 10 Year CFG 106.74 % 239.49 % 40.19 %
EPS Growth 81.52 % 27.73 % -0.68 %
EPS Diluted Growth 81.52 % 27.63 % -0.51 %
Book Value Per Share 0.65 % 21.99 % -0.85 %
Share Holder 3 Year Equity Growth Per Share 41.05 % 37.85 % -0.14 %
Share Holder 5 Year Equity Growth Per Share 142.4 % 93.34 % 3.99 %
Share Holder 10 Year Equity Growth Per Share 12.96 % 354.67 % 150.41 %
Dividend Per Share Growth - - 9.92 %
Dividend 3 Year Growth Per Share - - 9.92 %
Dividend 5 Year Growth Per Share - - 13.46 %
Dividend 10 Year Growth Per Share -100 % - 74.26 %
Debt Growth -3.4 % - -4.62 %
Free Cash Flow Growth 100.7 % 73.93 % -13.09 %
Updated On 31 Dec 2024 31 Dec 2024 30 Sep 2025
Profitability
DXR MDLN ISRG BDX BDXA ALC
Gross Profit Margin TTM 89.54 % 66.41 % 45.44 % 45.44 % 55.13 %
Return on Assets TTM 5.01 % 14.19 % 3.03 % 3.03 % 3.42 %
Return on Equity TTM 5.03 % 16.08 % 6.63 % 6.63 % 4.93 %
Return on Capital Employed TTM 5.39 % 16.05 % 5.48 % 5.48 % 4.98 %
Net Income Per EBT TTM 100 % 86.77 % 89.16 % 89.16 % 85.57 %
EBT Per Ebit TTM 92.85 % 112.41 % 73 % 73 % 86.96 %
EBIT Per Revenue TTM 271.25 % 29.3 % 11.8 % 11.8 % 14.38 %
Cash Flow To Debt Ratio TTM -13.31 % - 17.88 % 17.88 % 39.27 %
Receivables Turnover TTM 393.63 7.63 7.29 7.29 4.98
Payables Turnover TTM 16.09 11.09 - - 5.03
Inventory Turnover TTM - 1.81 3.06 3.06 1.88
Fixed Asset Turnover TTM - 186.61 % 312.12 % 312.12 % 197.54 %
Asset Turnover TTM 1.99 % 49.67 % 39.47 % 39.47 % 31.94 %
Operating Cash Flow Per Share TTM -0.01 8.3 11.97 11.97 4.16
Free Cash Flow Per Share TTM -0.01 6.37 9.32 9.32 3.23
Cash Per Share TTM - 1376.56 % 299.71 % 299.71 % 284.33 %
Operating Cash Flow Sales Ratio TTM -4.91 % 30.8 % 15.71 % 15.71 % 20.57 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.01 % 76.72 % 77.84 % 77.84 % 77.51 %
Cash Flow Coverage Ratios TTM -13.31 % - 17.88 % 17.88 % 39.27 %
Price To Free Cash Flows Ratio TTM -2035.3 89.08 21 21.43 24.01
Price To Operating Cash Flows Ratio TTM -2044.61 68.22 16.29 16.63 18.64
Price Cash Flow Ratio TTM -2044.61 68.22 16.29 16.63 18.64
Income Statement (TTM)
DXR MDLN ISRG BDX BDXA ALC
Revenue $0B $8.35B $21.84B $21.84B $9.91B
Gross Profit $0B $5.63B $9.92B $9.92B $5.51B
Gross Profit Ratio 100% 67.46% 45.44% 45.44% 55.61%
EBITDA $0B $2.81B $4.96B $4.96B $2.68B
Net Income $0B $2.32B $1.68B $1.68B $1.02B
EPS Diluted 0.11 6.42 5.83 5.83 2.05
Balance Sheet (MRQ)
DXR MDLN ISRG BDX BDXA ALC
Long Term Debt $0B $0.11B $17.62B $17.62B $4.97B
Total Liabilities $0B $2.31B $29.94B $29.94B $8.79B
Total Equity $0.04B $16.53B $25.39B $25.39B $21.55B
Total Investments $0.04B $7.05B $0.01B $0.01B $0.91B
Total Debt $0B $0.15B $19.18B $19.18B $5.14B
Total Assets $0.04B $18.84B $55.33B $55.33B $30.35B
Cash Flow Statement (TTM)
DXR MDLN ISRG BDX BDXA ALC
Net Income $0B $2.34B $1.68B $1.68B $1.02B
Inventory $0B $-0.83B $-0.41B $-0.41B $-0.05B
Dividends Paid $0B $0B $-1.2B $-1.2B $-0.13B
Operating Cash Flow $0B $2.42B $3.43B $3.43B $2.08B
Capital Expenditure $0B $-1.11B $-0.76B $-0.76B $-0.67B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 81.775
ANGO AngioDynamics, Inc. 11.44
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 120.56
ATRC AtriCure, Inc. 41.42
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 12.275
AZTA Azenta, Inc. 36.965
BAX Baxter International Inc. 20.55
BDX Becton, Dickinson and Company 205.305
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 17.125
BLFS BioLife Solutions, Inc. 26.38
COO The Cooper Companies, Inc. 84.31
EKSO Ekso Bionics Holdings, Inc. 9.56
FEMY Femasys Inc. 0.5929
ETFs With Exposure to DXR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00003 341.24
VUN.TO Vanguard U.S. Total Market Index ETF 0.00003 128.02
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00003 118.69
VGRO.TO Vanguard Growth ETF Portfolio 0.00001 43.83
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00001 55.13
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.43
VCNS.TO Vanguard Conservative ETF Portfolio 0.00001 31.78
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.06
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.66
VTSAX Vanguard Total Stock Market Index Fund 0.00003 164.94
VITSX Vanguard Total Stock Market Index Fund 0.00003 164.96
VTS.AX Vanguard US Total Market Shares Index ETF 0.00003 504.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00003 309.45
Unlock